Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 07:47:55 28/02/2017 +03 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.76M 2.55M 2.31M 4.32M 293M 4.38M 30.55M 12.17M 153M 11.56M 11.31M 487M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.26M 3.01M 2.73M 5.09M 346M 5.15M 35.98M 14.33M 181M 13.62M 13.33M 574M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+0.65%-3.36%+36.98%+60.50% 64.14B
+0.78%+2.48%+12.03%+83.54% 55.53B
+0.67%+1.11%+12.31%+103.92% 53.03B
+2.76%+0.87%+27.92%+55.07% 45.99B
+2.00%-3.39%+17.83%+119.04% 42.45B
+1.34%-2.86%+224.43%+914.08% 40.45B
+0.64%-3.95%+11.15%+45.57% 32.25B
-1.12%+42.88%+103.98%+90.46% 34.47B
-2.72%-0.44%+23.18%-10.77% 24.23B
Average +10.50%+13.67%+52.20%+162.38% 39.25B
Weighted average by Cap. +0.77%+3.49%+49.21%+160.28%

Financials

2017 2018
Net sales 16.01K 14.36K 13.28K 12.03K 22.47K 1.52M 22.74K 159K 63.24K 798K 60.08K 58.81K 2.53M 124 111.25 102.86 93.16 174.04 11.81K 176.14 1.23K 489.84 6.18K 465.32 455.5 19.62K
Net income -481K -432K -399K -361K -675K -45.81M -683K -4.77M -1.9M -23.97M -1.8M -1.77M -76.09M -976K -875K -809K -733K -1.37M -92.91M -1.39M -9.68M -3.85M -48.62M -3.66M -3.58M -154M
Net Debt 497K 446K 412K 373K 697K 47.31M 706K 4.93M 1.96M 24.76M 1.86M 1.82M 78.59M 548K 492K 455K 412K 770K 52.22M 779K 5.44M 2.17M 27.33M 2.06M 2.01M 86.75M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-